Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...

Published in Alzheimer’s & Dementia on Thursday, Oct. 24, the study found that semaglutide — the active ingredient in popular weight loss drugs like Ozempic and Wegovy — may be linked to ...

Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...

Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study. People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...

An analysis of over 100,000 medical records found that Ozempic users had a far lower dementia risk than those that took other diabetes drugs.

Ozempic linked with lower dementia risk, nicotine use, British study finds. July 12, 2024 at 1:40 PM. Copied (Reuters) - Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower ...

According to a study published on October 24, 2024, in the journal Alzheimer’s & Dementia, the type 2 diabetes and weight loss drug semaglutide (sold under the brand names Ozempic, Wegovy, and ...

Ozempic may lower dementia and nicotine dependence risk in people with type 2 diabetes. A recent study shows fewer cognitive deficits and lower smoking rates compared with other diabetes drugs.

Ozempic linked with lower dementia risk, nicotine use, British study finds FILE PHOTO: A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023.

Ozempic and similar novel diabetes treatments may lower the risk of Alzheimer's disease and related dementias.. This is the conclusion of a pair of studies by research teams from the U.S. and ...